Coloplast B A/S - stock earnings

COLO-B.CO Quarterly earnings

DateEarningsRevenue
2023Q4 1.2 billion DKK 6.6 billion DKK
2023Q3 1.2 billion DKK 6.2 billion DKK
2023Q2 1.3 billion DKK 6.1 billion DKK
2023Q1 1.2 billion DKK 6.1 billion DKK
2022Q4 1.1 billion DKK 6.1 billion DKK
2022Q3 1.2 billion DKK 6.1 billion DKK
2022Q2 1.3 billion DKK 5.8 billion DKK
2022Q1 980.0 million DKK 5.5 billion DKK
2021Q4 1.2 billion DKK 5.2 billion DKK
2021Q3 1.3 billion DKK 5.1 billion DKK
2021Q2 1.3 billion DKK 4.8 billion DKK
2021Q1 1.1 billion DKK 4.8 billion DKK
2020Q4 1.1 billion DKK 4.7 billion DKK
2020Q3 1.0 billion DKK 4.6 billion DKK
2020Q2 997.0 million DKK 4.4 billion DKK
2020Q1 1.1 billion DKK 4.8 billion DKK
2019Q4 1.1 billion DKK 4.7 billion DKK
2019Q3 793.0 million DKK 4.6 billion DKK
2019Q2 1.1 billion DKK 4.6 billion DKK
2019Q1 1.0 billion DKK 4.4 billion DKK
2018Q4 991.0 million DKK 4.3 billion DKK
2018Q3 1.0 billion DKK 4.2 billion DKK
2018Q2 948.0 million DKK 4.2 billion DKK
2018Q1 918.0 million DKK 4.0 billion DKK
2017Q4 940.0 million DKK 4.0 billion DKK
2017Q3 1.0 billion DKK 4.0 billion DKK
2017Q2 910.0 million DKK 3.9 billion DKK
2017Q1 931.0 million DKK 3.9 billion DKK
2016Q4 946.0 million DKK 3.8 billion DKK
2016Q3 424.0 million DKK 3.7 billion DKK
2016Q2 978.0 million DKK 3.7 billion DKK
2016Q1 916.0 million DKK 3.6 billion DKK
2015Q4 825.0 million DKK 3.7 billion DKK
2015Q3 -1.4 billion DKK 3.6 billion DKK
2015Q2 709.0 million DKK 3.5 billion DKK
2015Q1 815.0 million DKK 3.4 billion DKK
2014Q4 797.0 million DKK 3.3 billion DKK
2014Q3 841.0 million DKK 3.2 billion DKK
2014Q2 788.0 million DKK 3.1 billion DKK
2014Q1 -19.0 million DKK 3.0 billion DKK
2013Q4 780.0 million DKK 3.1 billion DKK
2013Q3 749.0 million DKK 3.0 billion DKK
2013Q2 710.0 million DKK 3.0 billion DKK
2013Q1 635.0 million DKK 2.8 billion DKK
2012Q4 617.0 million DKK 2.9 billion DKK
2012Q3 608.0 million DKK 2.8 billion DKK
2012Q2 588.0 million DKK 2.8 billion DKK
2012Q1 514.0 million DKK 2.7 billion DKK
2011Q4 484.0 million DKK 2.7 billion DKK
2011Q3 531.0 million DKK 2.6 billion DKK
2011Q2 485.0 million DKK 2.6 billion DKK
2011Q1 396.0 million DKK 2.5 billion DKK
2010Q4 407.0 million DKK 2.5 billion DKK
2010Q3 368.0 million DKK 2.5 billion DKK
2010Q2 337.0 million DKK 2.5 billion DKK
2010Q1 262.0 million DKK 2.3 billion DKK
2009Q4 276.0 million DKK 2.3 billion DKK
2009Q3 272.0 million DKK 2.3 billion DKK
2009Q2 221.0 million DKK 2.2 billion DKK
2009Q1 188.0 million DKK 2.1 billion DKK
2008Q4 202.0 million DKK 2.2 billion DKK

COLO-B.CO Yearly earnings

DateEarningsRevenue
2023 4.8 billion DKK 24.5 billion DKK
2022 4.7 billion DKK 22.6 billion DKK
2021 4.8 billion DKK 19.4 billion DKK
2020 4.2 billion DKK 18.5 billion DKK
2019 3.9 billion DKK 17.9 billion DKK
2018 3.8 billion DKK 16.4 billion DKK
2017 3.8 billion DKK 15.5 billion DKK
2016 3.1 billion DKK 14.7 billion DKK
2015 899.0 million DKK 13.9 billion DKK
2014 2.4 billion DKK 12.4 billion DKK
2013 2.7 billion DKK 11.6 billion DKK
2012 2.2 billion DKK 11.0 billion DKK
2011 1.8 billion DKK 10.2 billion DKK
2010 1.2 billion DKK 9.5 billion DKK
2009 883.0 million DKK 8.8 billion DKK
2008 715.0 million DKK 8.5 billion DKK
2007 370.0 million DKK 8.0 billion DKK
2006 466.0 million DKK 6.7 billion DKK
2005 553.0 million DKK 6.2 billion DKK
2004 587.9 million DKK 6.1 billion DKK
2003 561.0 million DKK 5.7 billion DKK
2002 768.0 million DKK 5.6 billion DKK

COLO-B.CO

Price: DKK849.20

52 week price:
689.20
993.00

Dividend Yield: 0.02%

5-year range yield:
0.02%
4.39%

Forward Dividend Yield: 3.80%

Payout Ratio: 143.43%

Payout Ratio Range:
34.52%
144.34%

Dividend Per Share: 32.00 DKK

Earnings Per Share: 22.31 DKK

P/E Ratio: 40.19

Exchange: CPH

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 509391

Market Capitalization: 205.6 billion

Average Dividend Frequency: 1

Years Paying Dividends: 36

DGR3: 5.27%

DGR5: 5.59%

DGR10: 2.85%

DGR20: 29.59%

Links: